Sign in

You're signed outSign in or to get full access.

Ryan Neal

Research Analyst at TD Cowen

Ryan Neal's questions to Cronos Group (CRON) leadership

Question · Q4 2025

Ryan Neal of TD Cowen asked about the key drivers behind the over 40% year-over-year growth in the Canadian domestic market, especially considering previous softer flower sales due to supply constraints in Q3. Ryan Neal then inquired about Cronos's strategy for deploying its substantial capital base, specifically regarding the current pipeline of potential M&A opportunities. Ryan Neal also asked for an update on the trending of recent innovation launches and which product categories are showing the most strength.

Answer

Chairman, President, and CEO Mike Gorenstein attributed the significant growth primarily to the availability of additional supply coming online, which allowed Cronos to meet existing demand in its Canadian markets. Mike Gorenstein reiterated commitment to the share repurchase program and highlighted international M&A as a focus, including expanding into new markets or acquiring new products/brands to leverage their existing platform, while maintaining a disciplined and opportunistic approach. Mike Gorenstein emphasized the importance of genetics (long-term, exciting projects), continued innovation in edibles (keeping SOURZ fresh), and particularly highlighted the strong early success of the new PUFFERZ all-in-one vape device as a significant driver.

Ask follow-up questions

Fintool

Fintool can predict Cronos Group logo CRON's earnings beat/miss a week before the call

Question · Q4 2025

Ryan Neal asked about the key drivers behind the over 40% year-over-year growth in the Canadian domestic market, particularly in light of previous softer flower sales due to supply constraints. He also inquired about Cronos Group's strategy for deploying its substantial capital base and an update on recent innovation launches.

Answer

Chairman, President, and CEO Mike Gorenstein attributed the strong Canadian performance primarily to the availability of additional supply. He reiterated commitment to the share buyback program and highlighted international opportunities, emphasizing a disciplined and opportunistic M&A approach. Mike Gorenstein highlighted ongoing success in genetics, continued innovation in edibles (SOURZ), and significant excitement around the new PUFFERZ all-in-one vape device.

Ask follow-up questions

Fintool

Fintool can write a report on Cronos Group logo CRON's next earnings in your company's style and formatting